Rett syndrome is a rare genetic disease affecting 1 in 10,000 newborn girls, characterized by sudden regression around 1 year ...

Zacks.com users have been paying close attention to CRISPR Therapeutics (CRSP). This makes it worthwhile to examine what the stock has in store.

The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.

Google has unveiled an AI co-scientist built on its Gemini 2.0 platform, aiming to accelerate scientific research by ...

CRISPR epigenome editing successfully reactivates silenced genes in Prader-Willi Syndrome, highlighting potential for ...

The new doors AI and machine learning are opening to scientists undoubtedly will invite weighty ethical and moral questions ...

A team of researchers from the University of Florida has developed an innovative handheld device for human immunodeficiency ...

Gene Editing Tool Market AnalysisThe global gene editing tool market is on the cusp of a revolutionary expansion, projected to grow at an impressive CAGR of 18.4% from 2024 to 2034. Valued at USD 688.

GeneCker showcases MUTE-Seq gene editing technology for cancer detection at AACR Biotechnology firm GeneCker to unveil ...

An artificial-intelligence network trained on a vast trove of sequence data is a step towards designing completely new ...

Agans is doing cutting-edge research in experimental genetics as a lab assistant and honors student in Jack Bateman’s lab.